Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Oleylphosphocholine

EU orphan designation number: EU/3/12/964   
Active ingredient: Oleylphosphocholine
Indication: Treatment of leishmaniasis
Sponsor: Oblita Therapeutics
Rodendijk 40, 2980 Zoersel, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/04/2012 Orphan designation EMA/OD/135/11 (2012)2896 of 23/04/2012
03/08/2016 Transfer of orphan designation EMA/OD/135/11/T/01 (2016)5125 of 01/08/2016